CNGB is about to announce strategic partnership with the GISAID Initiative.

By Mar 11, 2020, GISAID’s EpiCoV™ database has accumulated 461 hCoV-19 genome sequences submitted by researchers across the world.

To support the research on hCoV-19, the CNGB data platform (CNGBdb) published four genome assemblies of hCoV-19 on Jan 22, 2020 and later launched a hCoV-19 database integrating hCoV-19 genome sequence data from different platforms, hCoV-19 potential intermediate host datasets, and information of published research papers. By Mar 11, the CNGBdb database has collected 118 hCoV-19 genome sequences, of which 16 were published directly on CNGBdb.

CNGB has been playing a key role in the fight against COVID-19 in Guangdong Province, including the 20 million population of Shenzhen. As one of the network of emergency COVID-19 testing laboratories BGI established throughout the country, the Shenzhen Dapeng “Huo-Yan” ("Piercing Eyes") Lab came into service on Feb 15, 2020 and has provided over 80,000 tests for Shenzhen and the surrounding cities. The lab has now developed a throughput capability of up to 10,000 sample tests per day.